Landscapes / Biliary Tract Diseases

Bile Duct Diseases

24 drugs in active Bile Duct Diseases trials · Updated 18 Nov 2026

Furthest along
1 approved
8 in Phase 3
Next Phase 3 result
17 Dec 2026
Drugs
24
In active trials, any stage
Trials
38 active
5 sub-diseases included

Drugs24

DrugHow it worksCompanyStageNext dateDetails
Peroxisome proliferator-activated receptor agonist
Phase 3 17 Dec 2026soonPhase 3 trial completes
—
Phase 3 31 Dec 2026Phase 2 trial completes
Ileal bile acid transporter inhibitor
Phase 3 15 Feb 2027Phase 3 trial completes
—
Phase 3 18 Apr 2027Phase 3 trial completes
—
Phase 3 Sep 2027Phase 3 trial completes
Ileal bile acid transporter inhibitor
Phase 3 23 Oct 2028Phase 3 trial completes
—
Gilead (Kite) · Public GILD
Phase 3 Nov 2028Phase 3 trial completes
PD-1/TIGIT bispecific antibody
AstraZeneca · Public AZN
Phase 3 2 Jan 2029Phase 3 trial completes
—
Phase 2 31 Dec 2026Phase 2 trial completes
—
Phase 2 Jan 2027Phase 2 trial completes

See all 24 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

Included5

Sub-diseaseDrugsActive trialsTrials
Cholestasis
3 sub-diseases
1018
Cholangitis
1 sub-disease
79
Bile Duct Neoplasms99
Common Bile Duct Diseases
1 sub-disease
24
Biliary Atresia22

How trials write it1

The conditions trials list that we place on Bile Duct Diseases itself, with their active trials

Cholestatic Liver Disease 2

About

Summary
24 drugs are in active Bile Duct Diseases trials: 1 approved, 8 in Phase 3, 15 earlier. The next Phase 3 result expected is Elafibranor’s, 17 Dec 2026. Updated 18 Nov 2026.
Registry term
Bile Duct Diseases
Counts
Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
Sources
ClinicalTrials.gov updated 18 Nov 2026